{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:02:57Z","timestamp":1772830977080,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jocn.2013.06.013","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T21:46:28Z","timestamp":1377294388000},"page":"583-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI"],"prefix":"10.1016","volume":"21","author":[{"given":"In\u00eas Br\u00e1s","family":"Marques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Matias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Duarte","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.06.013_b0005","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2013.06.013_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","article-title":"The neuro-ophthalmology of multiple sclerosis","volume":"4","author":"Frohman","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0015","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(01)01209-0","article-title":"Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jocn.2013.06.013_b0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.10148","article-title":"Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses","volume":"51","author":"Beck","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.wnl.0000200778.65597.ae","article-title":"IM interferon beta-1a delays definite multiple sclerosis 5years after a first demyelinating event","volume":"66","author":"Kinkel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.06.013_b0035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.06.013_b0040","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.06.013_b0045","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe Study): a randomised, double blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.06.013_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(11)70262-9","article-title":"Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial","volume":"11","author":"Comi","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","article-title":"The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up","volume":"121","author":"O\u2019Riordan","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.06.013_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/brain\/116.1.135","article-title":"The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: a 5-year follow-up study","volume":"116","author":"Morrissey","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.06.013_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(06)70353-2","article-title":"MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study","volume":"5","author":"Korteweg","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ana.410410315","article-title":"Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis","volume":"41","author":"Jacobs","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0075","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","article-title":"Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF and HLA findings","volume":"50","author":"S\u00f6derstr\u00f6m","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.06.013_b0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2013.06.013_b0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1017\/S0317167100010519","article-title":"Predicting conversion to MS \u2013 the role of a history suggestive of demyelination","volume":"37","author":"Morrow","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2013.06.013_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jnnp.2008.166421","article-title":"Prior suggestive symptoms in one-third of patients consulting for a \u201cfirst\u201d demyelinating event","volume":"82","author":"Gout","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2013.06.013_b0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0105","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Poman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0115","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"Tintor\u00e9","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2013.06.013_b0120","first-page":"487","article-title":"Ocular manifestations of multiple sclerosis and relationship to retrobulbar neuritis","volume":"48","author":"Marshall","year":"1950","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jocn.2013.06.013_b0125","series-title":"Neuro-ophthalmology: the requisites","author":"Martin","year":"2000"},{"key":"10.1016\/j.jocn.2013.06.013_b0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2013.06.013_b0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awg038","article-title":"Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis","volume":"126","author":"Filippi","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2013.06.013_b0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1053-8119(03)00043-0","article-title":"Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis","volume":"18","author":"Rocca","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.jocn.2013.06.013_b0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00415-007-0666-9","article-title":"High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria","volume":"255","author":"Wattjes","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroimage.2005.11.051","article-title":"Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy","volume":"31","author":"Trip","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.jocn.2013.06.013_b0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0165","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00415-005-0655-9","article-title":"Predicting the outcome of optic neuritis: evaluation of risk factors after 30years of follow-up","volume":"252","author":"Nilsson","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2013.06.013_b0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-009-5063-0","article-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","volume":"256","author":"Mowry","year":"2009","journal-title":"J Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813004505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813004505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T19:24:42Z","timestamp":1539458682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586813004505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0967586813004505"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.06.013","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}